Pyrosequencing AB Reports Results for Third Quarter and Nine Months Ended September 30, 2000 --Company#s DNA sequencing

Pyrosequencing AB Reports Results for Third Quarter and Nine Months Ended September 30, 2000 --Company's DNA sequencing technology continues to penetrate global markets-- Uppsala, Sweden, October 25, 2000, Pyrosequencing AB (PYRO A: Stockholm) today reported financial results for the third quarter and nine months ended September 30, 2000. Commenting on the results, Erik Wallden, President and CEO stated, "We continue to make significant progress in sales of our sequencing instruments and reagents. During the quarter, we sold 11 PSQ 96 Systems and as of today, another 9 are on order, resulting in third quarter revenues that exceed the first half of the year. We also expanded our global customer base, adding several prestigious organizations including the National Institutes of Health, the National Cancer Center of Tokyo, and the Karolinska Institute. These accomplishments bring to light how our 'sequencing by synthesis' technology is rapidly becoming a standard for applied genetic analysis. " Recent accomplishments include: * Completed of a European sales organization and strengthened US sales initiatives * Increased the number of repeat sales, with five customers installing two or more systems * Sold PSQ 96 Systems to renowned academic institutes, including the National Institutes of Health, the National Cancer Center of Tokyo and the Karolinska Institute * Continued sales success in the pharmaceutical arena, including leaders AstraZeneca, SmithKline Beecham and Janssen Pharmaceutica. * Reagent kit sales increased above company´s expectations * Enhanced in-house software development capabilities * Initiated multi-city technology seminars in Europe and a U.S. tour scheduled in November. ------------------------------------------------------------ This information was brought to you by BIT http://www.bit.se The following files are available for download: http://www.bit.se/bitonline/2000/10/25/20001025BIT00840/bit0001.doc The full report http://www.bit.se/bitonline/2000/10/25/20001025BIT00840/bit0002.pdf The full report